SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-212499
Filing Date
2022-08-04
Accepted
2022-08-04 16:06:28
Documents
12
Period of Report
2022-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d385505d8k.htm   iXBRL 8-K 23688
  Complete submission text file 0001193125-22-212499.txt   149261

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA phat-20220801.xsd EX-101.SCH 2875
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE phat-20220801_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phat-20220801_pre.xml EX-101.PRE 11720
6 EXTRACTED XBRL INSTANCE DOCUMENT d385505d8k_htm.xml XML 3476
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39094 | Film No.: 221136498
SIC: 2834 Pharmaceutical Preparations